chrX-153740170-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM5PP3_Strong
The ENST00000218104.6(ABCD1):c.1567C>A(p.Leu523Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,210,121 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L523P) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000218104.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCD1 | NM_000033.4 | c.1567C>A | p.Leu523Ile | missense_variant | 6/10 | ENST00000218104.6 | NP_000024.2 | |
LOC124905226 | XR_007068350.1 | n.1378G>T | non_coding_transcript_exon_variant | 1/2 | ||||
ABCD1 | XM_047441916.1 | c.1867C>A | p.Leu623Ile | missense_variant | 7/11 | XP_047297872.1 | ||
ABCD1 | XM_047441917.1 | c.1623C>A | p.Gly541= | synonymous_variant | 7/8 | XP_047297873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCD1 | ENST00000218104.6 | c.1567C>A | p.Leu523Ile | missense_variant | 6/10 | 1 | NM_000033.4 | ENSP00000218104 | P1 | |
PLXNB3-AS1 | ENST00000434284.1 | n.72-1592G>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
ABCD1 | ENST00000443684.2 | n.570C>A | non_coding_transcript_exon_variant | 5/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112922Hom.: 0 Cov.: 24 AF XY: 0.0000285 AC XY: 1AN XY: 35068
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097199Hom.: 0 Cov.: 32 AF XY: 0.00000276 AC XY: 1AN XY: 362631
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112922Hom.: 0 Cov.: 24 AF XY: 0.0000285 AC XY: 1AN XY: 35068
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 10, 2020 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 26, 2023 | - - |
Adrenoleukodystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 28, 2023 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Leu523 amino acid residue in ABCD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21700483). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCD1 protein function. ClinVar contains an entry for this variant (Variation ID: 1213423). This sequence change replaces leucine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 523 of the ABCD1 protein (p.Leu523Ile). This variant is present in population databases (no rsID available, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ABCD1-related conditions. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.1567C>A (p.L523I) alteration is located in exon 6 (coding exon 6) of the ABCD1 gene. This alteration results from a C to A substitution at nucleotide position 1567, causing the leucine (L) at amino acid position 523 to be replaced by an isoleucine (I). Based on data from gnomAD, the A allele has an overall frequency of 0.005% (1/21901) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.009% (1/10749) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. Based on internal structural analysis, L523I is located near an interface, is moderately destabilizing to the local structure, and has nearby pathogenic variants with no nearby benign variants (Ambry internal analysis). The in silico prediction for this alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ABCD1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 07, 2024 | The ABCD1 c.1567C>A variant is predicted to result in the amino acid substitution p.Leu523Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0093% of alleles in individuals of European (non-Finnish) descent in gnomAD. An alternative nucleotide substitution affecting the same amino acid (p.Leu523Phe) has been reported to have arisen de novo in an individual with X-linked adrenoleukodystrophy (Table 2, Wang et al. 2011. PubMed ID: 21700483). Although we suspect that the c.1567C>A (p.Leu523Ile) variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at